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Introduction
Thromboangiitis obliterans (TAO), or Buerger's dis-
ease, is a non-atherosclerotic segmental, thrombotic,
inflammatory disease most commonly affecting the
small and medium sized arteries and veins of the upper
and lower distal extremities [1-4]. The disease was
proposed in 1908 by Buerger [1]. Although the exact
underlying cause of TAO is still unknown, the disease
is strongly associated with tobacco abuse, implicating
cigarette smoking as a primary etiologic factor
[3,5,6,7]. Affected patients are mostly young male
smokers, who develop ulcers and gangrene of the toes
and fingers as a result of the vascular ischaemia [5,8].
However, cases of women with TAO are becoming
more common, coinciding with an increased incidence
of smoking in this sex [9,10]. Although distal vessels
of lower and upper extremities are the most common-
ly involved, other vessels such as cerebral, mesenteric,
and coronary arteries can be rarely affected [11-14].
The diagnosis is based on characteristic clinical cri-
teria as well as pathological findings in arteriography
and histopathology; and there is no specific marker of
the disease yet [5,15]. Acute Buerger's disease is char-
acterized histopathologically by intensely cellular ves-
sel wall inflammation, total luminal obliteration by the
thrombus, together with a varying degree of recanal-
ization; however, the internal elastic lamina and the
overall vascular wall architecture remain preserved
[5,16]. Cell infiltration was observed mainly in the
thrombus and the intima. Macrophages expressing
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HLA-DR and dendritic cells are preferentially located
in the intima and these cells may present antigens
brought by the blood stream to CD4+ T lymphocytes
predominating in the infiltrate [17,18].
The pathogenesis of this disease is poorly under-
stood and most hypotheses are controversial
[4,7,16,18-20]. Accumulating clinical evidence point
to an inflammatory and immunological pathogenesis.
TAO is found to be associated with HLA-A9 and
HLA-B5 antigens as well as polymorphism of the
MICA gene [21,22]. A prothrombotic genetic factor
was claimed to be associated with the risk of TAO
[23]. Although most investigators speculate about an
autoimmune mechanism, no direct causative antigen
has yet been discovered [24,25]. However, an associa-
tion between anticardiolipin antibodies and this dis-
ease was reported [26]. Antiendothelial cell antibodies
were proposed to play a role in the pathogenesis of
TAO [27]. Various studies were undertaken to examine
the mechanism of the immune injury. An increased
cellular and humoral response to collagen [28,29], cir-
culating immune complexes [30,31], elevated anti-
elastin titers [32] and abnormal elastin degradation
[33] were reported. The altered production of IL-6, IL-
12 and IL-10, the increased apoptosis as well as the
elevated levels of circulating immune complexes were
proposed to be the reason for the persisting immune
inflammation in TAO [34]. The specificity of all these
findings remains to be established.
As little is known about the pathogenesis of the dis-
ease we aimed to determine novel antigens that might
be susceptible for the local reactions observed in this
disease with the reference of previous reports. For this
purpose we studied frozen sections of tissue samples
from dorsalis pedis artery of affected individuals per-
forming a screening using twenty monoclonal antibod-
ies. Among these were several antigens which are not
previously reported in TAO like CD34, CD44 and
CD90. Some cytokine/chemokine receptors, several
enzymes and leukocyte/lymphocyte antigens were also
targeted. We discussed the findings indicating possible
roles of these antigens or their absence in the develop-
ment of the disease aiming to direct future studies
including several novel antigens of yet unknown
specificity. 
Materials and methods
Specimens and sections. After obtaining an informed consent
and receiving approval from the institutional Ethics Committee
on human research, we have taken the tissue samples as partial
biopsy specimens from Department of Pathology, Dicle Univer-
sity Faculty of Medicine from two patients who were both men
and fulfilled all of Shionoya's clinical criteria for the diagnosis
of Buerger's disease: (1) smoking history; (2) onset before the
age of 50 years; (3) infrapopliteal arterial occlusions; (4) either
upper limb involvement or phlebitis migrans; and (5) absence of
atherosclerotic risk factors other than smoking [15]. Histopatho-
logical diagnosis of both cases were confirmed by the same
department.
The 43 year old patient had a smoking history of 13 years (20-
30/day). There was gangrene in the big toe and necrosis on the tips
of the 2nd and 3rd toes of his right foot. Big toe amputation and
right lomber sympathectomy operations were performed, because
there were no convenient distal arterial vessel detected with Dop-
pler USG and conventional angiography for the arterial by-pass
surgery. The part of the medial tarsal branch of the dorsalis pedis
artery which was within the amputated tissue was used for the
study. The other patient, 37 years old, had been a smoker for 9
years (20/day) prior to admission in our clinic. He was suffering
from pain and redness in the left foot and critical ischemia (in the
extreme) was observed on the big toe of his left foot when he was
admitted to the clinic. Doppler USG and conventional angiography
showed that the blood supply from the left popliteal artery was
only by weak, thin collaterals in some parts. Because there was no
convenient distal vessel for the arterial by-pass surgery, only left
lomber sympathectomy and left big toe amputation were per-
formed. The distal part of the dorsalis pedis artery within the
amputated tissue was taken for the study also in this case. 
Tissue samples from the dorsalis pedis artery of affected indi-
viduals were immediately frozen in liquid nitrogen, and stored in a
liquid nitrogen tank for 2-3 days until sectioned. Cryo-sections (6-
8µm thick) were taken with cryostat (Leica Frigocut 2800E, Wet-
zlar, Germany) on gelatin-coated slides and dried at room temper-
ature. Then the sections were kept in humidity-free containers at
room temperature until the staining was performed the day after. 
Antibodies and staining procedure. In order to perform the
screening, immunohistochemistry was performed using about twen-
ty monoclonal primary antibodies which are all generated in mice
including HI302, anti-vimentin, anti-CD10, anti-CD11c, anti-CD19,
anti-CD20, anti-CD22, anti-CD34, anti-CD44, anti-CD62E, anti-
CD80,  anti-CD90, anti-CD104, anti-CD106, anti-CD116, anti-
CD117, anti-CD123, anti-CD132,  anti-CD195 and anti-TARC as
listed in the Table 1. The immunostaining procedure previously
described is applied as follows [35]. Sections were fixed in acetone
for 10 minutes and air-dried for at least 30 minutes. Sections were
then incubated for 60 minutes at room temperature with monoclon-
al antibodies (mAbs) in a humidity chamber. The dilutions of the
mAbs used in the study are also given in Table 1. For negative con-
trols, primary antibodies were replaced by their non-immune iso-
types. After washing in phosphate buffered saline (PBS) pH 7.4, the
slides were incubated with a 1:200 dilution of anti-mouse IgG per-
oxidase (Sigma Cat no: A9044) in PBS containing 0.2% bovine
serum albumin (Sigma Cat no: A-7034) and 1% normal human
serum. After washing the slides with PBS, they were stained for per-
oxidase activity with 3.3'-diaminobenzidine-tetrahydrochloride
(DAB) (Sigma Cat no: D3939). Counterstaining with hematoxylin
was done. Sections were then examined by using a research micro-
scope (Leica DMR, Wetzlar, Germany) and images were obtained by
a digital camera (Leica DC500, Wetzlar, Germany). 
Results
Histopathological findings
In the samples examined the lumina of the affected
vessels were completely obliterated and microvessels
in intima serving as recanalizing vessels were evident.
Varying degrees of infiltrating mononuclear cells in
tunica intima were also present in both of the samples.
The tunica media was rather thick which is usually
considered as a characteristic feature of TAO when
compared to other obliterating pathologies like athero-
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sclerosis. Prominent internal elastic lamina also helps
to delineate intima and media layers. In addition, the
number of microvasculature was determined to be
increased also in tunica media. No significant patho-
logical change was observed in tunica adventitia. 
Immunohistochemical findings
Control: In both control stainings (which the primary
antibodies were replaced by their non-immune iso-
types) no reaction was determined in all layers of
affected vessels. 
No significant reaction was detected for the follow-
ing antigens: CD10 (CALLA- zinc metallo-peptidase),
CD19, CD20, CD22, CD62E, CD80, CD116 (GM-
CSF receptor alpha chain), CD132 (IL2RG; common
cytokine receptor gamma chain; common gamma) and
TARC (Thymus and Activation-Regulated
Chemokine).
Reactive antigens and their reactivity pattern are
summarized below.
A- Structural/stromal/endothelial antigens
Vimentin: A weak to moderate reaction was present in
the vascular smooth muscle including the tunica media
of the artery itself (Fig. 1). Vimentin immunoreactivi-
ty helped to reveal all calibers of vasculature in the tis-
sue samples examined. Intimal and adventitial fibrob-
lasts were also reactive for the antigen. 
CD104: Weak to moderate expression on the vas-
cular smooth muscle and endothelial layer was
observed, though not typically reflecting the linear tis-
sue distribution of this integrin chain along the basal
lamina.
CD34: The antigen is well recognized as a hemo-
poietic stem cell marker and it was strongly expressed
by all of the microvascular endothelial cells present in
the sections (Figs. 2a and 2b). These vessels were
located in intima (recanalizing vessels), media and
adventitia of the affected vessel. Reaction to this anti-
gen was clearly restricted to the endothelial lining and
revealed how extensive were the newly formed vessels
in tunica intima. A significant finding observed by the
expression of this antigen was the presence of exten-
sive microvasculature in tunica media (which was
somehow surprising being at this extent), in addition to
intima and adventitia. This finding was more promi-
nent at a higher magnification in Fig. 2b.
CD44: CD44 antigen was expressed by some vas-
cular endothelial cells, fibroblasts in intima, media and
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Table 1. The specificity, clone name, source and dilutions of primary antibodies used in this study are listed. HLDA WS VIII, Human
Leukocyte Differentiation Antigens Workshop VIII; CD, cluster of differentiation.
especially in adventitia and elongated cells (fibrob-
lasts) along internal elastic lamina.
CD90: A moderate to strong reaction was present
on fibroblasts but the antigen was also strongly
expressed by all of the endothelial cells and vascular
smooth muscle of newly formed vasculature in the
lumen (Fig. 3).
CD106 (VCAM-1): This antigen was expressed by
the microvascular endothelial cells and some mononu-
clear cells in the samples examined. Those vessels
reactive for the antigen were the recanalization vessels
in the intima.
HI302 monoclonal antibody (Endothelial cell
marker): This endothelial cell antigen revealed the
extensive vascular network along the whole thickness
of the affected vessel wall (Fig. 4). As most endothelial
cell antigens were also weakly reactive with vascular
smooth muscle, this antigen reflected a unique sample
which was absent on vascular smooth muscle cells.
B- Leukocyte/lymphocyte  antigens
CD11c: CD11c antigen was detected on some cells
with dendritic processes and also on blood mononu-
clear cells in the vessel lumen (Fig. 5). The cells
observed in the vessel wall were macrophages; how-
ever, some of them may also represent dendritic cells
which cannot be excluded. 
CD195 (CCR5): This macrophage specific antigen
revealed macrophages with their dendritic processes.
Such reactive cells were present in all three layers of
the vessel wall, but the presence of many reactive cells
in tunica media was a bit surprising (Fig. 6).
CD117: Expression of c-KIT (stem cell factor
receptor, SCFR) was found only in a few endothelial
cells. 
CD123: IL3-R alpha chain expression was deter-
mined only on the endothelial lining of some small
vessels in the sections. 
Discussion
Although the disease is well described about a century
ago, we still know little about the mechanisms of the
onset and progress of TAO, probably because only a
restricted number of samples are available for exami-
nation. So far, only several immunohistochemical
studies on this immune-induced, tobacco triggered dis-
ease were performed. In one of the studies, linear dep-
osition of immunoglobulins and complement factors
along the internal elastic lamina and presence of acti-
vated macrophages, B- and T-cells especially in the
intima of the affected vessels have been demonstrated
[17]. Kim et al. have reported that the immunologic
injury to the internal elastic lamina is associated with
T-lymphocytic infiltration and this might be the initial
morphogenetic mechanism of the thrombotic occlu-
sion and organization of medium-sized arteries in TAO
[16]. In another study, among the infiltrating cells, T-
helper cells outnumbered cytotoxic T cells and the
expression of VCAM-1 as well as iNOS were
observed in endothelial cells around the intima or
occluded segment [18]. In an immunohistochemical
light and electron microscopical study to analyze the
expression of TNFα, ICAM-1, VCAM-1 and E-
selectin in surgical biopsies obtained from femoral and
iliac arteries of patients with TAO, it is indicated that
endothelial cells are activated in TAO and that vascu-
lar lesions are associated with TNFα secretion by tis-
sue-infiltrating inflammatory cells [36]. Kurata et al.
presented histological and immunohistochemical char-
acteristics of TAO that would be helpful in a differen-
tial diagnosis from arteriosclerosis obliterans (ASO)
and thromboembolism [6,7]. In the subset of definite
TAO cases, the macrophages, and B- and T-lympho-
cytes were mostly found in close vicinity to internal
elastic lamina and adventitia, often following the
recanalizing vessels and vasa vasorum, suggesting that
minute vessels and elastic fibers are specific targets of
the inflammatory reaction in TAO [7]. It has been sug-
gested that immunovasculitic disorder and dysfunction
of the microvascular endothelial cells are the unifying
frame of this vaso-occlusive disease, which is super-
imposed and modified by immune responses to nor-
mally hidden antigenic determinants of the vascular
intima [6,7]. Nishikimi et al. also postulated that there
is a breakdown of the microvascular defense system
from the beginning of the disease [37]. In the current
study we aimed to determine novel antigens hoping to
obtain evidence on the nature of the development of
the disease with special regard to inflammatory
process and structural changes. 
From a structural point of view, both of the samples
examined in this study fulfilled the previously report-
ed histopathological characteristics of the disease.
Expression patterns of vimentin, CD104 and CD44
reflected the expected features of stromal component
organization. One of our most interesting findings was
the presence of numerous vessels also in tunica media
which is not reported as a distinct histopathological
finding. Examining vasculature using endothelial cell
reactive antibodies like anti-CD34, HI302 and anti-
CD90 helped greatly to determine the extent of the
vascular network as well as its structural organization.
Similar findings were observed in the illustrations of a
previous report by Kurata et al [7], however authors
did not stress this finding. In our opinion, it is not sur-
prising to have a similar reaction in adjacent compart-
ments of a vessel facing the same local stimuli for
angiogenesis and/or vasculogenesis. Moreover, CD90
(Thy-1) was strongly expressed by vasculature and by
some stromal cells (fibroblasts and mesenchymal stem
137Novel antigens in Buerger's disease
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2010:48(1): 137 (134-141) 
10.2478/v10042-008-0104-6
138 E. Guzel et al.
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2010:48(1): 138 (134-141) 
10.2478/v10042-008-0104-6
cells?) in the neighboring connective tissue compart-
ments. It is suggested that this glycophosphatidylinos-
itol (GPI)-anchored immunoglobulin family member
has a signaling function in various physiological and
pathological events including thymocyte maturation,
axon regeneration, apoptosis, adhesion, cancer, fibro-
sis, leukocyte recruitment and angiogenesis. CD90
also helps to characterize mesenchymal stem cell pop-
ulations [38-44]. In our study, a strong and broad
expression of CD90 supports the view that this antigen
is involved in the new vessel formation in tunica inti-
ma and media of the affected vessels in TAO. It was
previously reported that human Thy-1 (CD90) on acti-
vated endothelial cells serves as a counterreceptor for
the leukocyte integrin Mac-1 (CD11b/CD18) [42]. We
examined CD11c, another leukocyte integrin, and a
strong expression of this antigen was determined on
mononuclear cells in some samples. This finding
together with CD90 expression by vascular endothelial
cells in the involved tissue suggests that CD11c prob-
ably serves as another ligand for leukocyte migration
for this antigen in TAO. CD90 may have a role in
leukocyte (and/or other cell types) recruitment to the
effected site of the vessel. Taken together, both find-
ings suggest that CD90 is at least one of the key mol-
ecules involved in the pathogenesis of the disease. Our
attempt to find out other antigens like CD106 (VCAM)
and CD62E with a similar documented role as CD90
was not fruitful, as CD62E was completely lacking,
and CD106 was expressed by the endothelial lining of
few vessels and few mononuclear cells. Therefore,
these molecules may play roles in the earlier stages of
the disease, but probably not after the disease is com-
pletely settled down. 
High endothelial venules are specific postcapillary
venules located in diffuse lymphoid tissue compart-
ments of secondary lymphoid organs and at chronic
inflammatory sites, such as the synovial tissues in
rheumatoid arthritis [45,46]. In our samples, we did
not observe a high endothelial venule, which indicates
that continuous and pronounced lymphocyte migration
to the lesion side is not present. B cell differentiation -
maturation and/or activation markers, such as CD10,
CD19, CD20 and CD22 were also lacking, suggesting
that there is no B cell infiltration and antibody produc-
tion locally. We also looked for TARC (Thymus and
activation regulated chemokine) and CCR5 (CD195)
expression to examine if this chemokine and chemokine
receptor are involved in this process. TARC is reported
to be a chemokine directing migration of CD4+Th2
lymphocytes which suppresses local inflammatory reac-
tion [47]. CCR5 is a receptor for RANTES, MIP-1α and
MIP-1β playing a dominant role in immune reactions
like graft versus host disease, multiple sclerosis and
rheumatoid arthritis [48-51]. TARC was not present in
any of the TAO samples but CCR5 expression was
determined on macrophages (some of which may repre-
sent dendritic cells). The absence of TARC may be con-
sidered as a sign of limited local suppression of inflam-
mation. Similarly, the absence of several cytokine
receptors, such as CD116 (GM-CSFR α chain), CD117
(Stem Cell Factor- cKIT receptor), CD123 (IL3-R α-
chain), CD132 (IL-2R γ chain: common γ chain recep-
tor for cytokine receptors) suggests that they are not
involved in this process. On the other hand, the protein
expression of CCR5 suggests a possible role for this
receptor in TAO. CD80, a co-regulator of T cell activa-
tion with CD86, is involved in the alloactivation of T
cells and known to play a critical role in autoimmune,
humoral, and transplant responses. It is expressed on
activated B cells, activated T cells and macrophages
[52-55]. CD80 was also absent in TAO samples exam-
ined in this study. 
In conclusion, in addition to the major involvement
site intima, the involvement of tunica media is critical,
regarding new vessel formation and macrophage / den-
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Fig. 1. In a frozen section through dorsalis pedis artery the lumen of the vessel is seen to be completely obliterated due to TAO. Intact
internal elastic lamina (arrows) indicates the border of tunica intima. Several sections of varying sizes of recanalizing vessels in the lumen
of the vessel are observed (asterix). Vascular smooth muscle of both the artery itself and the newly developed recanalizing vessels is reac-
tive for vimentin. Intimal and adventitial fibroblasts are also reactive. Indirect immunoperoxidase – hematoxylin counterstained, original
magnification ×10. Fig. 2. Immunohistochemical staining for CD34 antigen: (a) Strong CD34 reactivity on the endothelial lining of all
vasculature is observed. Inset: Higher magnification of the area consisting of internal elastic lamina at lower left diagonal; several ves-
sels in intima are evident. Indirect immunoperoxidase – hematoxylin counterstained, original magnification ×10; inset ×20. (b) Expres-
sion of the same antigen at a higher magnification. Intima consists of numerous recanalizing vessels. Internal elastic lamina delineates
intima and media. More interesting finding is the presence of numerous vessels also in media. One of them is observed extending from
adventitia into media (arrow head). Indirect immunoperoxidase – hematoxylin counterstained, original magnification ×20. Fig. 3. A broader
reactivity pattern for CD90 antigen is detected. In addition to endothelial cells, vascular smooth muscle and some fibroblasts are also reac-
tive. Asterix: lumina of the vasculature. Arrow: internal elastic lamina. Indirect immunoperoxidase – hematoxylin counterstained, origi-
nal magnification ×10. Fig. 4. Immunoreactivity of HI302 mAb. Strong reactivity with almost all vascular endothelial cells is observed.
Arrows: internal elastic lamina. Indirect immunoperoxidase – hematoxylin counterstained, original magnification ×10. Fig. 5. Cells with den-
dritic processes are reactive (moderate to strong) for CD11c antigen. A large mononuclear cell in the lumen of a small vessel also exhibits
a strong membranous reaction (inset). Indirect immunoperoxidase – hematoxylin counterstained, original magnification ×10 (inset origi-
nal magnification ×40). Fig. 6. Cells with processes are reactive for CD195 antigen detected by 1M2D7 monoclonal antibody. As the anti-
gen is specific to macrophages it is somehow surprising to observe many reactive cells in tunica media (arrow heads). Arrow: internal
elastic lamina. Indirect immunoperoxidase – hematoxylin counterstained, original magnification ×10. 
dritic cell infiltration presumably participating in the
complex pathogenesis of the disease. Among all the
screened antigens, CD90 (Thy1) represents the most
prominent one. Taken together with the expression of
CD11c on macrophages/dendritic cells it can be sug-
gested that this molecule pair is possibly involved in
cellular recruitment to the affected vessel wall. CCR5
expression also suggests a role for this chemokine in
this process. The present findings provide preliminary
data indicating further examinations in greater detail
will be valuable.
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